Literature DB >> 32638562

Coexisting COPD Increases Mortality in Patients With Corticosteroid-Dependent Asthma: A Nationwide Population-Based Study.

Hyun Lee1, Jiin Ryu2, Sung Jun Chung1, Dong Won Park1, Jang Won Sohn1, Ho Joo Yoon1, Sang Heon Kim3.   

Abstract

PURPOSE: Chronic corticosteroid (CS) use is a risk factor for long-term mortality in asthmatic patients, and the presence of coexisting chronic obstructive pulmonary disease (COPD) is associated with a severe presentation and poor prognosis. However, the impact of coexisting COPD on long-term mortality in patients with CS-dependent asthma has not been well elucidated. This study aimed to determine the impact of coexisting COPD on long-term mortality in patients with CS-dependent asthma.
METHODS: A retrospective cohort of patients with CS-dependent asthma aged 40 years or older was established using records from the Korean National Health Insurance Service database for 2005 to 2015. We classified the subjects into 2 groups according to the presence of COPD and evaluated the hazard ratio (HR) for all-cause mortality in patients with COPD relative to those without COPD.
RESULTS: Of 8,021 patients with CS-dependent asthma, 3,121 (38.9%) had COPD. All-cause mortality was significantly greater in patients with CS-dependent asthma and COPD than in those without COPD (9,955/100,000 person-years vs. 5,585/100,100 person-years, P < 0.001). The adjusted HRs were 1.29 (95% confidence interval [CI], 1.21-1.38), and the associations were especially significant for chronic lower respiratory diseases (subdistribution HR, 2.30; 95% CI, 2.06-2.57) and lung cancer (subdistribution HR, 1.34; 95% CI, 1.02-1.78).
CONCLUSIONS: In this population-based retrospective cohort study, the presence of physician-recognized COPD was associated with greater all-cause mortality and greater risk of mortality due to chronic lower respiratory diseases and lung cancer in patients with CS-dependent asthma. Early recognition and appropriate management of COPD can improve treatment outcomes in patients with CS-dependent asthma.
Copyright © 2020 The Korean Academy of Asthma, Allergy and Clinical Immunology · The Korean Academy of Pediatric Allergy and Respiratory Disease.

Entities:  

Keywords:  Mortality; asthma; chronic obstructive pulmonary disease; population; steroids; treatment

Year:  2020        PMID: 32638562     DOI: 10.4168/aair.2020.12.5.821

Source DB:  PubMed          Journal:  Allergy Asthma Immunol Res        ISSN: 2092-7355            Impact factor:   5.764


  4 in total

1.  Association between exercise and risk of cardiovascular diseases in patients with non-cystic fibrosis bronchiectasis.

Authors:  Hayoung Choi; Sang Hyuk Kim; Kyungdo Han; Tai Sun Park; Dong Won Park; Ji-Yong Moon; Sang-Heon Kim; Tae-Hyung Kim; Jang Won Sohn; Ho Joo Yoon; Hyun Lee
Journal:  Respir Res       Date:  2022-10-18

2.  Additive effects of coexisting respiratory comorbidities on overall or respiratory mortality in patients with asthma: a national cohort study.

Authors:  Yoomi Yeo; Hyun Lee; Jiin Ryu; Kyung Hoon Min; Ji-Yong Moon; Sung Jun Chung; Tai Sun Park; Dong Won Park; Sang-Heon Kim; Tae Hyung Kim; Jang Won Sohn; Ho Joo Yoon
Journal:  Sci Rep       Date:  2022-05-16       Impact factor: 4.996

3.  A nationwide survey of the association between nonalcoholic fatty liver disease and the incidence of asthma in Korean adults.

Authors:  Jae-Hyung Roh; Hanbyul Lee; Bae Yun-Jeong; Chan Sun Park; Hyo-Jung Kim; Sun-Young Yoon
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

Review 4.  Status of Studies Investigating Asthma-Chronic Obstructive Pulmonary Disease Overlap in Korea: A Review.

Authors:  Yong Suk Jo
Journal:  Tuberc Respir Dis (Seoul)       Date:  2021-12-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.